The global Neonatal Phototherapy Market is a critical sector of pediatric healthcare dedicated to treating neonatal jaundice (hyperbilirubinemia), a condition affecting approximately 60% of term newborns and 80% of preterm infants. Phototherapy uses specific wavelengths of blue-green light to convert unconjugated bilirubin into water-soluble isomers that the infant's body can excrete. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/